BEŞİROĞLU, M. Et Al. 2015. Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma. Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015 .

BEŞİROĞLU, M., TANRIKULU ŞİMŞEK, E., Halil, S., Kaya, S., DANE, F., BOZKURT, S., ... ATASOY, B. M.(2015). Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma . Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015

BEŞİROĞLU, MEHMET Et Al. "Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma," Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015, 2015

BEŞİROĞLU, MEHMET Et Al. "Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma." Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015 , 2015

BEŞİROĞLU, M. Et Al. (2015) . "Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma." Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015 .

@conferencepaper{conferencepaper, author={MEHMET BEŞİROĞLU Et Al. }, title={Efficacy of second line bevacizumab and irinotecan treatment in high grade glioma}, congress name={Trends in Central Nervous System Malignancies, EORTC EANO ESMO Conference 2015}, city={}, country={}, year={2015}}